Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Dec 24.
Published in final edited form as: Psychiatry Res. 2012 Jul 11;200(0):10.1016/j.psychres.2012.06.039. doi: 10.1016/j.psychres.2012.06.039

Cholesterol fractions, symptom burden, and suicide attempts in mood disorders

Jane E Persons a, William H Coryell b, Jess G Fiedorowicz a,b,c
PMCID: PMC3871860  NIHMSID: NIHMS537703  PMID: 22789841

To the Editors

Low total cholesterol has been associated with suicide (Coryell and Schlesser, 2007) though this has been subject to debate with most research focused on total cholesterol. In a recent review of studies that included cholesterol fractions, Troisi (2009) noted that low levels of low-density lipoprotein cholesterol (LDL-c) have been most consistently (four studies) implicated in suicidal behavior and impulsivity, while low levels of high-density lipoprotein cholesterol (HDL-c) have been more strongly associated with negative mood and depressive symptomatology. Our aim was to determine the relationship between serum HDL-c and LDL-c and course of illness and prior suicide attempts in a well-characterized sample of individuals with mood disorders. We hypothesized individuals with a history of suicide attempts would have lower LDL-c and that depressive symptom burden would be inversely related to HDL-c levels.

Our sample included 35 Caucasian adults with major depression or bipolar disorder who completed a mean (standard deviation (S.D.)) of 26.8 (1.2) and up to 30 years of follow-up in the Collaborative Depression Study. Participants were recruited for a study of vascular function in mood disorders, described in greater detail elsewhere (Fiedorowicz et al., 2012). Long-term course of illness was assessed using the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987), which tracks weekly ratings of clinically significant depressive symptoms, collected previously over twenty-four to thirty years. Participants provided separate written consents for the Collaborative Depression Study and this cross-sectional evaluation through protocols approved by the University of Iowa Institutional Review Board.

Of the 35 study participants, 11 (31.4%) had at least one suicide attempt, as previously defined (Fiedorowicz et al., 2009), during the Collaborative Depression Study follow-up period. We found there to be no significant difference (p=0.24) in mean LDL-c levels between individuals with a history of suicide attempts (129.8 (27.7) mg/dL) and individuals with no documented history of suicide attempt (117.9 (25.5) mg/dL), nor did we detect a significant difference (p=0.52) in mean (S.D.) HDL-c levels between attempters (53.1 (15.0) mg/dL) and non-attempters (56.0 (11.4) mg/dL). Depressive symptom burden was correlated with neither HDL-c (r=0.10, p=0.56) nor LDL-c (r=0.09, p=0.62) levels. Those with categorically low HDL-c (N=6, <40 mg/dL) had a non-significantly lesser, rather than greater, depressive symptom burden (26% vs. 31% of follow-up weeks, t=0.41, d.f.=33, p=0.68).

To date, research on cholesterol and suicide has focused primarily on total serum cholesterol; few studies have attempted to characterize the relationship between serum cholesterol fractions and suicide risk. Prior studies have recruited cases shortly after the attempt, wherein low cholesterol could be a consequence of weight loss secondary to depression. Our long-term prospective cohort design rigorously assesses suicide attempts over long-term follow-up and measures cholesterol fractions outside of the acute suicide attempt. However, our small sample increases the risk of type II error, limiting the ability to establish an association between HDL-c and LDL-c serum levels and outcome measures though results were in the opposite direction hypothesized. Large, well-designed studies will be required to clarify what is certainly a complex relationship between serum lipids and clinical variables relevant to mood disorders.

Acknowledgments

This study was funded by a NARSAD Young Investigator Award (J.G. Fiedorowicz) from the Brain & Behavior Research Foundation. The CDS sites sampled were funded by the National Institute of Mental Health5R01MH025416-33 (W. Coryell) and 5R01MH025430-33 (J. Rice). Dr. Fiedorowicz is also supported by the National Institute of Mental Health (1K23MH083695-01A210).

References

  1. Coryell W, Schlesser M. Combined biological tests for suicide prediction. Psychiatry Research. 2007;150:187–191. doi: 10.1016/j.psychres.2006.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fiedorowicz JG, Leon AC, Keller MB, Solomon DA, Rice JP, Coryell WH. Do risk factors for suicidal behavior differ by affective disorder polarity? Psychological Medicine. 2009;39:763–771. doi: 10.1017/S0033291708004078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG. Vasculopathy related to manic/hypomanic symptom burden and first generation antipsychotics in a sub-sample from the Collaborative Depression Study (CDS) Psychotherapy and Psychosomatics. 2012;81:235–243. doi: 10.1159/000334779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Keller MB, Lavori PW, Friedman B, Nielen E, Endicott J, McDonald-Scott P, Andreason NC. The longitudinal interval follow-up evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry. 1987;44:540–548. doi: 10.1001/archpsyc.1987.01800180050009. [DOI] [PubMed] [Google Scholar]
  5. Troisi Cholesterol in coronary heart disease and psychiatric disorders: same or opposite effects on morbidity risk? Neuroscience and Biobehavioral Reviews. 2009;33(2):125–132. doi: 10.1016/j.neubiorev.2008.09.003. [DOI] [PubMed] [Google Scholar]

RESOURCES